Tandem Diabetes Care Inc
(FRA:TD5A)
€
29.8
0.92 (3.19%)
Market Cap: 1.99 Bil
Enterprise Value: 2.02 Bil
PE Ratio: 0
PB Ratio: 9.19
GF Score: 78/100 Tandem Diabetes Care Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 26, 2021 / 05:00PM GMT
Release Date Price:
€77.55
(-6.86%)
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior Analyst
Good afternoon, everyone. Thank you so much for joining us at the SVB Leerink Global Healthcare Conference. And my name is Danielle Antalffy. I'm one of the senior medtech analysts here at SVB Leerink. We are very lucky to have with us from Tandem Diabetes CEO John Sheridan and CFO Leigh Vosseller. We also have Investor Relations on the line as well, but she is hiding right now, Susan Morrison. But I'm sure she'll jump in as needed. So guys, thanks for joining us, guys and gals.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
Hi. Danielle. How are you?
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior Analyst
Good. Thank you. So this is a timely -- from the perspective of you just did report your Q4 earnings, a tremendous feat again. And you issued 2021 guidance ahead of the Street and I wanted to maybe start there.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot